Press release
Antifungal Drugs Market Analysis By 2023 -Pfizer Inc., Sanofi S.A., Gilead Sciences, Inc., Merck & Co., Inc., Novartis International AG, Abbott Laboratories, Bayer AG, Scynexis Inc., Enzon Pharmaceuticals, Inc., and GlaxoSmithKline Plc.
Global Antifungal Drugs Market is expected to rise from $13,719 million in 2016 to $17,718 million by 2023. The industry is anticipated to register a CAGR of 3.7%, during the forecast period, 2017 - 2023. The antifungal drugs detect and eliminate fungal pathogens providing minimal side effect to the body. The fungal infection in the body is caused due to unhygienic and unclean environments wherein fungal agent thrive. These agents multiply by spreading spores that subsequently lead to infection on skin (superficial) or when inhaled (systemic)-fungal infections. The fungal infection leads to candidiasis, fungal pneumonia, mucormycosis, and other diseases. These infections are mostly non-lethal, but can result in death in rare cases.
Request for a sample of reports :
https://www.alliedmarketresearch.com/request-sample/2370
Continuous focus of key players towards the development of new generic as well as innovative anti-infective drugs and formulation technologies to combat serious fungal infections drive the antifungal drugs market. This is evident from the various launches made by many major players. For instance, Basilea Pharmaceutica Ltd. launched CRESEMBA (isavuconazole) in UK, in 2016. This is a new azole antifungal drug prescribed for treatment of mucormycosis.
The global antifungal drugs market is segmented based on drug type, therapeutic indications, dosage forms, infection type, and geography. Based on drug type, it is classified into echinocandins, azoles, polyenes, allylamines, and other drugs. Furthermore, based on therapeutic indications the market is categorized into aspergillosis, dermatophytosis, candidiasis, and others. In terms of dosage forms, it is divided into powders, ointments, drugs, and pastes. Based on infection type, the market is bifurcated into superficial and systemic antifungals. Geographically, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. Among the drug type, azole occupied three-eighths of the total market share in 2016. This is the highest amongst all, and is expected to maintain this trend during the forecast period. The trend is noticed due to rise in awareness about drug availability and fungal infections, globally. In the indication type, the dermatophytosis is expected to grow at the highest CAGR of 4.1% during the forecast period.
Drivers, Restraints, and Opportunities
Factors that accelerate demand for the antifungal drugs market are growth in prevalence of fungal infection, rise in awareness levels pertaining to myriad fungal infections, and increase in demand for the drugs to combat the related diseases. However, presence of counterfeit drugs and resistance toward antifungal drugs restrict the market growth. In addition, increase in R&D expenditure coupled with funding from the public & private sector is expected to provide lucrative growth opportunities to the industry.
India Antifungal Drugs Market
The rise in awareness toward personal care drives the antifungal drugs market growth in India. In addition, India provides a tropical environment for breeding of diverse types of fungi, and therefore provides a lot of opportunities to the pharmaceutical vendors to keep the drug market flooded with various anti-fungal drugs. Hence, the antifungal drugs market is expected to flourish in the near future in India.
The report provides a comprehensive analysis of the key players operating in the global antifungal drugs market, such as Pfizer Inc., Sanofi S.A., Gilead Sciences, Inc., Merck & Co., Inc., Novartis International AG, Abbott Laboratories, Bayer AG, Scynexis Inc., Enzon Pharmaceuticals, Inc., and GlaxoSmithKline Plc.
The other players of the global antifungals drugs market include Astellas Pharma, Inc., Sigma-Aldrich Corporation, Agilent Technologies, Inc., Beckman Coulter, Inc. (a subsidiary of Danaher Corporation), Kramer Laboratories, Basilea Pharmaceutical Ltd., Valeant Pharmaceuticals International, Inc., and Tecan Group.
For more details , Do Visit :
https://www.alliedmarketresearch.com/antifungal-drugs-market
Key Benefits of the Antifungal Drugs Market Report:
It provides an in-depth analysis of the market with current trends and future estimations to elucidate the imminent investment pockets
It offers discussion to enable the stakeholders to capitalize on the prevailing market opportunities
It profiles key market players and their strategies which help to understand the competitive outlook of the market
It incorporates the Porters Five Forces model to interpret the bargaining power of suppliers & buyers, threat of new entrants & substitutes, and competition among the key players
Antifungal Drugs Market Key Segments:
By Drug Type
• Echinocandins
• Caspofungin
• Micafungin
• Anidulafungin
• Others
Azoles
• Imidazoles
• Voricanazole
• Thiazoles
• Others
Polyenes
• Amphotericin B
• Candicidin
• Hamycin
• Natamycin
• Others
Allylamines
• Butenafine
• Terbinafine
• Naftifine
• Others
By Infection Type
• Superficial Antifungal Infections
• Systemic Antifungal Infections
By Therapeutic Indications
• Aspergillosis
• Dermatophytosis
• Candidiasis
• Others
By Dosage Forms
• Powders
• Ointments
• Drugs
• Others
Request for a purchase enquiry :
https://www.alliedmarketresearch.com/purchase-enquiry/2370
About Us:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Antifungal Drugs Market Analysis By 2023 -Pfizer Inc., Sanofi S.A., Gilead Sciences, Inc., Merck & Co., Inc., Novartis International AG, Abbott Laboratories, Bayer AG, Scynexis Inc., Enzon Pharmaceuticals, Inc., and GlaxoSmithKline Plc. here
News-ID: 1302861 • Views: …
More Releases from Allied Market Research
Global Urinary Drainage Bags Market: Trends, Growth, and Insights to 2031
The global urinary drainage bags market is experiencing robust growth, with its market size valued at $1.4billion in 2021 and projected to reach $2billion by 2031. This expansion represents a compound annual growth rate (CAGR) of 3.8% from 2021 to 2031, highlighting the increasing demand for these essential medical devices.
Get a Sample Copy of this Report: https://www.alliedmarketresearch.com/request-sample/A17529
What Are Urinary Drainage Bags?
Urinary drainage bags are specialized medical devices designed to collect…
Cream Powder Market to Reach $8.9 Billion by 2031 with 6.4% CAGR
The global cream powder industry was estimated at $4.8 billion in 2021 and is expected to hit $8.9 billion by 2031, registering a CAGR of 6.4% from 2022 to 2031.
The cream powder market is experiencing growth due to various factors, including the increasing popularity of bakeries and HoReCa (hotels, restaurants, and cafes) and rising consumer demand for natural products. The dairy-based segment is a significant contributor to the market's growth…
Micro Drone Market Valued at $6.71 Billion in 2020, Expected to Reach $28.91 Bil …
The global micro drone industry generated $6.71 billion in 2020, and is expected to reach $28.91 billion in 2030, witnessing a CAGR of 17.2% from 2021 to 2030. The report provides an extensive analysis of changing market dynamics, top segments, top investment pockets, regional landscape, value chain, and competitive scenario.
Increased operational efficiency and rise in demand for improved surveillance drive the growth of the global micro drone market. However, strict…
Microwavable Foods Market to reach $230.93 billion by 2031, growing at a CAGR of …
The global microwaveable foods industry was accounted for $120.45 billion in 2020, and is expected to reach $230.93 billion by 2031, growing at a CAGR of 5.6% from 2022 to 2031.
Rise in popularity of fast-food restaurants and large population base coupled with increase in number of quick-service restaurants drive the global microwaveable foods market. However, lack of awareness about microwavable foods hinders the market growth. On the contrary, rise in…
More Releases for Antifungal
Antifungal Drugs Market: Size, Share, Growth, Trends, and Forecast
Antifungal Drugs Market is estimated to witness substantial growth, increasing from a valuation of USD 14.8 billion in 2022 to a robust USD 20.9 billion by 2032. This expansion is forecasted to occur at a Compound Annual Growth Rate (CAGR) of 3.5% over the period of 2023-2032.
An Emerging Focus on Non-invasive Treatments and Personalized Plans
As medical technology advances, the antifungal drugs market has seen a trend towards non-invasive treatments. Patients…
Antifungal Drug Market Report Up to 2031
Visiongain has published a new report on Antifungal Drugs Market Report to 2031 : market is segmented by type (Azoles, Echinocandins, Polyenes), By Application (Aspergillosis, Dermatophytosis, Candidiasis, Others), by Administration (Drugs, Powders, Others) by Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa). The report includes detailed Profiles of Leading Antifungal Drugs Companies. PLUS COVID-19 Recovery Scenarios.
The study covers detailed and insightful chapters on market overview, market…
Global Antifungal Drug Market Analysis (2020-2025)
Global Info Research offers a latest published report on Antifungal Drug Analysis and Forecast 2020-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key global Antifungal Drug Concentrate players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
Click to view the full report TOC, figure and tables:
https://www.globalinforesearch.com/reports/516187/antifungal-drug
Market…
Global Antifungal Coatings Market Insights, Forecast to 2025|Global Market Playe …
An up-to-date research report has been disclosed by Market Research Hub highlighting the title “Global Antifungal Coatings Market Insights, Forecast to 2025” which provides an outlook for current market value as well as the expected growth of Antifungal Coatings Market during 2018-2025. The report studies the casing heads market worldwide, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, size, growth, revenue, consumption, import and export…
Global Antifungal Drugs Market Research Report 2017
Report Hive Market Research Released a New Research Report of 116 pages on Title " Global Antifungal Drugs Market Research Report 2017 "with detailed Analysis, Forecast and Strategies.
In this report, the global Antifungal Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.
Geographically, this report is segmented…
Antifungal Drugs Market Estimated to Flourish by 2024
Antifungal drugs medication is done for treating fungal infections with minimal side effects on the body. Basically this fungal infections are organism that feed by breaking down the living tissue these fungi are commonly known as dermatophytes. Dermatophytes can cause infection of the skin, hair and nail as they have a unique ability to utilize the keratin. There are some common fungal infections such as ringworm, athlete’s foot, fungal n…
